http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research. http://medicalxpress.com/news/2013-03-multi-tasking-imatinib-boosts-radiotherapy-bladder.html Cancer Mon, 04 Mar 2013 09:00:02 EST news281605894 (Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, which was made by researchers at Karolinska Institutet, might one day lead to better forms of treatment for patients with MS. http://medicalxpress.com/news/2013-02-cancer-drug-treatment-multiple-sclerosis.html Medical research Thu, 21 Feb 2013 10:02:01 EST news280663311 (HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said Friday. http://medicalxpress.com/news/2013-01-gleevec-latest-pediatric-cancer.html Cancer Fri, 25 Jan 2013 16:55:35 EST news278355318 Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. http://medicalxpress.com/news/2012-08-drugs-treatment-options-high-risk-childhood.html Cancer Mon, 13 Aug 2012 12:52:00 EST news264081090 (HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, according to a study published online May 21 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2012-05-regorafenib-metastatic-gi-stromal-tumors.html Cancer Wed, 23 May 2012 13:40:01 EST news256998413 Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks. The advance in mice suggests that a combination approach to therapy might stamp out chronic myeloid leukemia (CML) for good. http://medicalxpress.com/news/2012-04-leukemia-dreaded-stem-cells.html Cancer Thu, 05 Apr 2012 12:00:10 EST news252844867 A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that imatinib is the treatment of choice for these patients. http://medicalxpress.com/news/2012-02-drug-leukemia-patients-benefit-therapy.html Cancer Mon, 27 Feb 2012 05:09:06 EST news249541736 By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats – an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center. http://medicalxpress.com/news/2012-02-reformulated-imatinib-morphine-tolerance-lab.html Medications Tue, 21 Feb 2012 10:06:47 EST news249041188 Although significant progress has been made in treating chronic myeloid leukemia, the disease cannot yet be eliminated in all patients, and that challenge must be addressed, states a commentary in CMAJ (Canadian Medical Association Journal). http://medicalxpress.com/news/2012-01-chronic-myeloid-leukemia-won.html Cancer Mon, 23 Jan 2012 13:24:10 EST news246547439 (Medical Xpress) -- Cancer Research UK-funded scientists at The Institute of Cancer Research (ICR) have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped responding to a targeted drug, according to research published in Cancer Cell today. http://medicalxpress.com/news/2011-12-scientists-resistance-standard-leukaemia-drug.html Cancer Fri, 09 Dec 2011 08:37:06 EST news242642206 Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius Research Centre, K.U. Leuven, under the direction of Peter Carmeliet, have investigated the role of placental growth factor (PlGF) in mice with CML. Blocking this growth factor increases the life expectancy of these mice, even in those resistant to imatinib. http://medicalxpress.com/news/2011-06-efficient-therapy-specific-leukemia.html Cancer Tue, 14 Jun 2011 10:01:28 EST news227264422